← Eichor
Study identifier: NCT07231029 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment

Condition: Patients With Mild or Moderate Hepatic Impairment  ·  Sponsor: Taisho Pharmaceutical Co., Ltd.

PhasePhase 1
Planned participants24
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

An open-label study to evaluate the effect of TS-172 administration on pharmacokinetics in patients with hepatic impairment

This description comes directly from the study's public registry record.

Talk to the study team

Taisho Pharmaceutical Co., Ltd.  ·  81-3-3985-1118  ·  shu_chiken@taisho.co.jp

Always discuss trial participation with your own doctor first.

Locations (1)

Taisho Pharmaceutical Co., Ltd selected siteTokyo, JapanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07231029